366 related articles for article (PubMed ID: 11121914)
1. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis.
Almasio PL; Floreani A; Chiaramonte M; Provenzano G; Battezzati P; Crosignani A; Podda M; Todros L; Rosina F; Saccoccio G; Manenti F; Ballardini G; Bianchi FP; Scheuer PJ; Davies SE; Craxì A
Aliment Pharmacol Ther; 2000 Dec; 14(12):1645-52. PubMed ID: 11121914
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
[TBL] [Abstract][Full Text] [Related]
3. Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.
Battezzati PM; Zuin M; Crosignani A; Allocca M; Invernizzi P; Selmi C; Villa E; Podda M
Aliment Pharmacol Ther; 2001 Sep; 15(9):1427-34. PubMed ID: 11552915
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.
Vuoristo M; Färkkilä M; Karvonen AL; Leino R; Lehtola J; Mäkinen J; Mattila J; Friman C; Seppälä K; Tuominen J
Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
Kaplan MM; Cheng S; Price LL; Bonis PA
Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
Lindor KD; Dickson ER; Baldus WP; Jorgensen RA; Ludwig J; Murtaugh PA; Harrison JM; Wiesner RH; Anderson ML; Lange SM
Gastroenterology; 1994 May; 106(5):1284-90. PubMed ID: 8174890
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver.
Parés A; Caballería L; Rodés J; Bruguera M; Rodrigo L; García-Plaza A; Berenguer J; Rodríguez-Martínez D; Mercader J; Velicia R
J Hepatol; 2000 Apr; 32(4):561-6. PubMed ID: 10782903
[TBL] [Abstract][Full Text] [Related]
8. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
Batts KP; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
Poupon RE; Eschwège E; Poupon R
J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
Lee YM; Kaplan MM
Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study.
Eriksson LS; Olsson R; Glauman H; Prytz H; Befrits R; Rydén BO; Einarsson K; Lindgren S; Wallerstedt S; Wedén M
Scand J Gastroenterol; 1997 Feb; 32(2):179-86. PubMed ID: 9051880
[TBL] [Abstract][Full Text] [Related]
12. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC.
Battezzati PM; Podda M; Bianchi FB; Naccarato R; Orlandi F; Surrenti C; Pagliaro L; Manenti F
J Hepatol; 1993 Mar; 17(3):332-8. PubMed ID: 8315262
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol.
Bonis PA; Kaplan M
Gastroenterology; 1999 Aug; 117(2):395-9. PubMed ID: 10419921
[TBL] [Abstract][Full Text] [Related]
15. The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study.
Lindor KD; Dickson ER; Jorgensen RA; Anderson ML; Wiesner RH; Gores GJ; Lange SM; Rossi SS; Hofmann AF; Baldus WP
Hepatology; 1995 Oct; 22(4 Pt 1):1158-62. PubMed ID: 7557866
[TBL] [Abstract][Full Text] [Related]
16. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial.
Leuschner M; Maier KP; Schlichting J; Strahl S; Herrmann G; Dahm HH; Ackermann H; Happ J; Leuschner U
Gastroenterology; 1999 Oct; 117(4):918-25. PubMed ID: 10500075
[TBL] [Abstract][Full Text] [Related]
17. Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis.
Leung J; Bonis PA; Kaplan MM
Clin Gastroenterol Hepatol; 2011 Sep; 9(9):776-80. PubMed ID: 21699802
[TBL] [Abstract][Full Text] [Related]
18. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid for primary biliary cirrhosis.
Gluud C; Christensen E
Cochrane Database Syst Rev; 2002; (1):CD000551. PubMed ID: 11869580
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with long-term follow up.
Hwang SJ; Chan CY; Lee SD; Wu JC; Tsay SH; Lo KJ
J Gastroenterol Hepatol; 1993; 8(3):217-23. PubMed ID: 8100153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
